SCHEMBL8907257

SCHEMBL8907257

O=c1[nH]c2c([nH]c1=O)-c1ccccc1C2=NO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CDK5 Q00535 4/20 0.39
CDK5R1 Q15078 4/20 0.39
KDM4E B2RXH2 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
MAPT P10636 2/20 0.37
NCOA1 Q15788 2/20 0.37
NCOA3 Q9Y6Q9 2/20 0.37
HSP90AA1 P07900 2/20 0.37
APAF1 O14727 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
PAX8 Q06710 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8907252 1.00 MEN1 (0.50) MEN1KMT2ACDK5CDK5R1KDM4E
SCHEMBL8907251 1.00 MEN1 (0.50) MEN1KMT2ACDK5CDK5R1KDM4E
SCHEMBL8907372 0.73 POLB (0.67) MEN1KMT2AKDM4EGRIN2DGRIN3B
SCHEMBL29493736 0.71 KMT2A (0.94) MEN1KMT2ACDK5CDK5R1MAPT
SCHEMBL3401938 0.71 KMT2A (0.94) MEN1KMT2ACDK5CDK5R1MAPT
SCHEMBL8907637 0.71 USP8 (0.48) MEN1KMT2ARAB9AUSP8MAPK10
SCHEMBL17988338 0.70 MEN1 (0.71) MEN1KMT2ACDK5CDK5R1KDM4E
SCHEMBL8908230 0.69 KMT2A (0.41) MEN1KMT2ACDK5CDK5R1MAPT
SCHEMBL8908233 0.69 KMT2A (0.41) MEN1KMT2ACDK5CDK5R1MAPT
SCHEMBL7845913 0.69 PDE2A (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP claimed
US-5646146-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1997-07-08 US claimed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP claimed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO claimed
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP disclosed
US-5646146-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1997-07-08 US disclosed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP disclosed
US-5468748-A Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex NOVO NORDISK A/S (DK) 1995-11-21 US disclosed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO disclosed